Serum and urinary golgi membrane protein 1 (GOLM1/GP73/G73) for chronic kidney disease staging - Top-Institutions - MDSpire

Serum and urinary golgi membrane protein 1 (GOLM1/GP73/G73) for chronic kidney disease staging

  • By

  • Jiaqi Xu

  • Jiawen Lin

  • Chao Ma

  • Jianishaya Yeerlan

  • Shuping Li

  • Wenjian Zhu

  • Zhihua Zheng

  • Mingcheng Huang

  • July 10, 2026

  • 0 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    The Seventh Affiliated Hospital, Sun Yat-Sen University
    The Seventh Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Nephrology

  • #2

    Kyushu University Hospital
    Kyushu University Hospital

    Fukuoka, Fukuoka

    Key Differentiators

    • Nephrology

  • #3

    Mansoura University Hospital
    Mansoura University Hospital

    Mansoura, Dakahlia

    Key Differentiators

    • Nephrology

  • #4

    Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai

    Key Differentiators

    • Nephrology

  • #5

    RUBY study
    RUBY study

    N/A, N/A

    Key Differentiators

    • Nephrology

Original Source(s)

Serum and urinary golgi membrane protein 1 (GOLM1/GP73/G73) for chronic kidney disease staging

  • by Jiaqi Xu, Jiawen Lin, Chao Ma, Jianishaya Yeerlan, Shuping Li, Wenjian Zhu, Zhihua Zheng, Mingcheng Huang

  • July 10, 2026

Related Content

Side Effects: Bro Science, Actually

Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.

Prolonged Sleep Restriction May Increase Body Weight

In a pooled analysis of two randomized crossover trials, reducing nightly sleep by about 1.5 hours for 6 weeks was associated with modest increases in body weight and waist circumference without measurable changes in body composition.

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.